RVMD — Revolution Medicines, Inc.
Materials · Biological Products, (No Diagnostic Substances) · Nasdaq
2Insiders filing
30Transactions
+$1.5MReported buys
−$29.9MReported sells
0Cluster events
Insiders
| Insider | Role | Txns | Reported value |
|---|---|---|---|
| GOLDSMITH MARK A | See Remarks | 20 | $18.4M |
| Cislini Jeff | General Counsel | 10 | $13.0M |
Transaction history
| Filing date | Trade date | Ticker | Insider | Type | Shares | Price | Value | Cluster |
|---|---|---|---|---|---|---|---|---|
| 2026-08-25 | 2026-08-21 | RVMD | Cislini Jeff General Counsel 10b5-1 | M routine | 29,680 | $18.56 | +$551k | |
| 2026-08-25 | 2026-08-21 | RVMD | Cislini Jeff General Counsel 10b5-1 | M routine | 26,600 | $21.61 | +$575k | |
| 2026-08-25 | 2026-08-21 | RVMD | Cislini Jeff General Counsel 10b5-1 | S | 3,400 | $207.24 | −$705k | |
| 2026-08-25 | 2026-08-21 | RVMD | Cislini Jeff General Counsel 10b5-1 | S | 17,323 | $208.37 | −$3.6M | |
| 2026-08-25 | 2026-08-21 | RVMD | Cislini Jeff General Counsel 10b5-1 | S | 25,817 | $209.25 | −$5.4M | |
| 2026-08-25 | 2026-08-21 | RVMD | Cislini Jeff General Counsel 10b5-1 | S | 2,540 | $210.26 | −$534k | |
| 2026-08-25 | 2026-08-21 | RVMD | Cislini Jeff General Counsel 10b5-1 | S | 4,500 | $211.34 | −$951k | |
| 2026-08-25 | 2026-08-21 | RVMD | Cislini Jeff General Counsel 10b5-1 | S | 3,314 | $212.06 | −$703k | |
| 2026-08-25 | 2026-08-21 | RVMD | Cislini Jeff General Counsel 10b5-1 | M routine | 29,680 | — | — | |
| 2026-08-25 | 2026-08-21 | RVMD | Cislini Jeff General Counsel 10b5-1 | M routine | 26,600 | — | — | |
| 2026-08-25 | 2026-08-21 | RVMD | GOLDSMITH MARK A See Remarks 10b5-1 | M routine | 80,000 | $4.73 | +$378k | |
| 2026-08-25 | 2026-08-21 | RVMD | GOLDSMITH MARK A See Remarks 10b5-1 | S | 5,128 | $207.23 | −$1.1M | |
| 2026-08-25 | 2026-08-21 | RVMD | GOLDSMITH MARK A See Remarks 10b5-1 | S | 24,917 | $208.37 | −$5.2M | |
| 2026-08-25 | 2026-08-21 | RVMD | GOLDSMITH MARK A See Remarks 10b5-1 | S | 35,938 | $209.26 | −$7.5M | |
| 2026-08-25 | 2026-08-21 | RVMD | GOLDSMITH MARK A See Remarks 10b5-1 | S | 3,813 | $210.25 | −$802k | |
| 2026-08-25 | 2026-08-21 | RVMD | GOLDSMITH MARK A See Remarks 10b5-1 | S | 6,583 | $211.33 | −$1.4M | |
| 2026-08-25 | 2026-08-21 | RVMD | GOLDSMITH MARK A See Remarks 10b5-1 | S | 3,621 | $212.08 | −$768k | |
| 2026-08-25 | 2026-08-21 | RVMD | GOLDSMITH MARK A See Remarks 10b5-1 | S | 190 | $207.25 | −$39k | |
| 2026-08-25 | 2026-08-21 | RVMD | GOLDSMITH MARK A See Remarks 10b5-1 | S | 951 | $208.36 | −$198k | |
| 2026-08-25 | 2026-08-21 | RVMD | GOLDSMITH MARK A See Remarks 10b5-1 | S | 1,351 | $209.28 | −$283k | |
| 2026-08-25 | 2026-08-21 | RVMD | GOLDSMITH MARK A See Remarks 10b5-1 | S | 136 | $210.40 | −$29k | |
| 2026-08-25 | 2026-08-21 | RVMD | GOLDSMITH MARK A See Remarks 10b5-1 | S | 245 | $211.47 | −$52k | |
| 2026-08-25 | 2026-08-21 | RVMD | GOLDSMITH MARK A See Remarks 10b5-1 | S | 127 | $212.06 | −$27k | |
| 2026-08-25 | 2026-08-21 | RVMD | GOLDSMITH MARK A See Remarks 10b5-1 | S | 177 | $207.25 | −$37k | |
| 2026-08-25 | 2026-08-21 | RVMD | GOLDSMITH MARK A See Remarks 10b5-1 | S | 937 | $208.36 | −$195k | |
| 2026-08-25 | 2026-08-21 | RVMD | GOLDSMITH MARK A See Remarks 10b5-1 | S | 1,405 | $209.27 | −$294k | |
| 2026-08-25 | 2026-08-21 | RVMD | GOLDSMITH MARK A See Remarks 10b5-1 | S | 126 | $210.40 | −$27k | |
| 2026-08-25 | 2026-08-21 | RVMD | GOLDSMITH MARK A See Remarks 10b5-1 | S | 229 | $211.46 | −$48k | |
| 2026-08-25 | 2026-08-21 | RVMD | GOLDSMITH MARK A See Remarks 10b5-1 | S | 126 | $212.06 | −$27k | |
| 2026-08-25 | 2026-08-21 | RVMD | GOLDSMITH MARK A See Remarks 10b5-1 | M routine | 80,000 | — | — |
No transactions match these filters.